LH2 Promotes Tumor Progression in Oral Squamous Cell Carcinoma via EPHA7-AKT-VEGF Signaling
Background Lysyl hydroxylase 2 (LH2) specifically hydroxylates lysine residues in type I collagen telopeptides. Aberrant LH2 expression has been implicated as a driver of aggressive phenotypes in multiple cancers, including oral squamous cell carcinoma (OSCC). However, the intracellular signaling mechanisms activated b...